Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.

BMJ : British Medical Journal
FUTURE I/II Study GroupRichard Haupt

Abstract

To evaluate the prophylactic efficacy of the human papillomavirus (HPV) quadrivalent vaccine in preventing low grade cervical, vulvar, and vaginal intraepithelial neoplasias and anogenital warts (condyloma acuminata). Data from two international, double blind, placebo controlled, randomised efficacy trials of quadrivalent HPV vaccine (protocol 013 (FUTURE I) and protocol 015 (FUTURE II)). The trials were to be 4 years in length, and the results reported are from final study data of 42 months' follow-up. Primary care centres and university or hospital associated health centres in 24 countries and territories around the world. 17 622 women aged 16-26 years enrolled between December 2001 and May 2003. Major exclusion criteria were lifetime number of sexual partners (>4), history of abnormal cervical smear test results, and pregnancy. Three doses of quadrivalent HPV vaccine (for serotypes 6, 11, 16, and 18) or placebo at day 1, month 2, and month 6. Vaccine efficacy against cervical, vulvar, and vaginal intraepithelial neoplasia grade I and condyloma in a per protocol susceptible population that included subjects who received all three vaccine doses, tested negative for the relevant vaccine HPV types at day 1 and remained negative ...Continue Reading

References

May 1, 1996·International Journal of STD & AIDS·P ClarkeS Stewart
Apr 23, 2002·JAMA : the Journal of the American Medical Association·Diane SolomonUNKNOWN Bethesda 2001 Workshop
Sep 28, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D J WileyLynne Fukumoto
Feb 7, 2003·The New England Journal of Medicine·Nubia MuñozUNKNOWN International Agency for Research on Cancer Multicenter Cervical Cancer Study Group
May 27, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ralph P InsingaEvan R Myers
Jan 30, 2004·Annual Review of Medicine·Kathrin U Jansen, Alan R Shaw
Aug 6, 2004·American Journal of Obstetrics and Gynecology·Ralph P InsingaBrenda B Rush
Aug 17, 2004·International Journal of STD & AIDS·Paul C LangleySusan M Drake
Mar 9, 2005·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Charles J N Lacey
May 17, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Gary M CliffordJeanne M Pimenta
Jan 20, 2006·The Journal of Reproductive Medicine·Mario SideriSallie Neill
Oct 31, 2006·Gynécologie, obstétrique & fertilité·C BergeronV Rémy
Nov 24, 2006·The American Journal of Surgical Pathology·Monica SrodonRobert J Kurman
May 15, 2007·The New England Journal of Medicine·UNKNOWN FUTURE II Study Group
May 15, 2007·The New England Journal of Medicine·Suzanne M GarlandUNKNOWN Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators
Nov 17, 2007·The Journal of Infectious Diseases·Susanne Krüger KjaerMari Nygård

❮ Previous
Next ❯

Citations

Apr 30, 2013·Clinical Rheumatology·Mariele GattoYehuda Shoenfeld
Aug 6, 2011·Advances in Therapy·Sherri N Sheinfeld GorinRebecca B Perkins
Feb 1, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kristin A SwedishStephen E Goldstone
Jun 28, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Maria BlombergSusanne K Kjaer
Jun 20, 2012·The Journal of Infectious Diseases·Deborah Watson-JonesRichard Hayes
Mar 15, 2013·Journal of the National Cancer Institute·Amy LevalLisen Arnheim-Dahlström
Mar 15, 2013·Journal of the National Cancer Institute·Jennifer S Smith, Elisabete Weiderpass
Apr 12, 2012·Clinical Microbiology Reviews·Margaret A Stanley
Jun 4, 2011·Sexually Transmitted Infections·S C WoodhallUNKNOWN QOLIGEN study group
Aug 5, 2011·Sexually Transmitted Infections·Sarika DesaiKate Soldan
Jun 16, 2012·BMC Medical Research Methodology·Edward K WatersDavid G Regan
Mar 5, 2013·BMC Infectious Diseases·Leonardo M SimonellaKaren Canfell
Jan 26, 2013·BMC Infectious Diseases·Harshila PatelSmita Kothari
Apr 2, 2011·BMC Public Health·Vernon J LeeMei Yin Tok
Feb 9, 2013·BMC Public Health·Andrea LenziCarla Maria Zotti
Jul 2, 2011·International Journal for Equity in Health·Janice E Graham, Amrita Mishra
Feb 12, 2013·International Journal for Equity in Health·Ivan BrankovićIneke Klinge
Oct 22, 2010·Infectious Agents and Cancer·Margaret Stanley
Jun 14, 2013·Infectious Agents and Cancer·David HawkesMatthew J Berryman
Jul 12, 2014·Sexually Transmitted Diseases·Allison L NalewayEileen F Dunne
Nov 28, 2014·Proceedings. Biological Sciences·Carmen Lía MurallTroy Day
Oct 1, 2011·Drug Delivery and Translational Research·Jeremy S BlumW Mark Saltzman
Jun 6, 2013·Nature Reviews. Clinical Oncology·Matti Lehtinen, Joakim Dillner
Aug 15, 2012·Current Oncology Reports·Anne Szarewski
Aug 9, 2011·Expert Review of Anti-infective Therapy·Julia M L Brotherton, Dorota M Gertig
Dec 14, 2011·Expert Review of Clinical Immunology·Wilhelmina M HustonKenneth W Beagley
Jun 5, 2013·Obstetrics and Gynecology Clinics of North America·Leda GattocKevin Ault
Oct 30, 2012·The Journal of Infection·Carol ChelimoJ Mark Elwood
May 15, 2012·Annales de dermatologie et de vénéréologie·F Aubin
Dec 26, 2012·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Chin-Chih LeeLi-Min Huang
May 17, 2011·Joint, Bone, Spine : Revue Du Rhumatisme·François AubinDaniel Wendling

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
biopsies

Clinical Trials Mentioned

NCT00092521
NCT00092534

Software Mentioned

SAS

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.